| For: | Kang SW, Lim SH, Kim MJ, Lee J, Park YS, Lim HY, Kang WK, Kim ST. Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1. World J Gastrointest Oncol 2024; 16(8): 3521-3528 [PMID: 39171162 DOI: 10.4251/wjgo.v16.i8.3521] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i8/3521.htm |
| Number | Citing Articles |
| 1 |
Ghanshyam Biswas, Sumit Goyal, Amit Rauthan, Syed Mujtaba Hussain Naqvi, Sunil Kumar Yadav Yadagiri, Gauri Debashish Dhanaki, Arti Sanghavi, Rohit Kumar, Sagar Katare, Bhavesh P Kotak. Real-World Experience With Panitumumab or Bevacizumab as a First-Line Treatment for Metastatic Colorectal Cancer: An Indian Perspective. Cureus 2025; doi: 10.7759/cureus.97914
|
| 2 |
Yuan Qin, Fu-Yuan Ma, Zhi Zhang, Chen-Hao Zhao, Biao Huang. Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatment. World Journal of Gastrointestinal Oncology 2024; 16(11): 4514-4517 doi: 10.4251/wjgo.v16.i11.4514
|
